Can dextran-based nanoparticles mitigate inflammatory lung diseases?

Future Med Chem. 2021 Dec;13(23):2027-2031. doi: 10.4155/fmc-2021-0218. Epub 2021 Oct 1.
No abstract available

Keywords: acetalated dextran; aerosolized formulations; dextran; dry powder inhalers; mucus permeation; nanocomposite microparticle (nCmP); pulmonary delivery; respiratory diseases; siRNA delivery; theranostics.

Publication types

  • Editorial

MeSH terms

  • Dextrans / chemistry*
  • Drug Carriers / chemistry
  • Drug Delivery Systems
  • Humans
  • Inflammation / drug therapy*
  • Lung Diseases / drug therapy*
  • Nanoparticles / chemistry*
  • RNA, Small Interfering / chemistry
  • RNA, Small Interfering / therapeutic use*

Substances

  • Dextrans
  • Drug Carriers
  • RNA, Small Interfering